JHL1149 (bevacizumab biosimilar) / Eden Biologics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
JHL1149 (bevacizumab biosimilar) / Eden Biologics
NCT03576651: A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers

Checkmark Trial initiation in Europe
Jul 2018 - Jul 2018: Trial initiation in Europe
Completed
1
154
Europe
JHL1149, Bevacizumab
JHL Biotech, Inc.
Healthy Male Subjects
09/18
12/19

Download Options